RIV production involves the insertion of the gene encoding the HA protein into a virus or bacteria, which then expresses the HA protein. This protein is subsequently harvested and purified to create the vaccine. This process eliminates the need for egg-based production, making it suitable for individuals with egg allergies and allows for more rapid production and scalability.
